Allergen Sensitization and Asthma Outcomes among World Trade Center Rescue and Recovery Workers by Rojano, Belen et al.
City University of New York (CUNY) 
CUNY Academic Works 
Publications and Research Queens College 
2019 
Allergen Sensitization and Asthma Outcomes among World Trade 
Center Rescue and Recovery Workers 
Belen Rojano 
Icahn School of Medicine at Mount Sinai 
Erin West 
Icahn School of Medicine at Mount Sinai 
Emily Federmann 
Icahn School of Medicine at Mount Sinai 
Steven Markowitz 
CUNY Queens College 
Denise Harrison 
New York University 
See next page for additional authors 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/qc_pubs/374 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
Authors 
Belen Rojano, Erin West, Emily Federmann, Steven Markowitz, Denise Harrison, Laura Crowley, Paula 
Busse, Alex D. Federman, and Juan P. Wisnivesky 
This article is available at CUNY Academic Works: https://academicworks.cuny.edu/qc_pubs/374 




Allergen Sensitization and Asthma Outcomes among
World Trade Center Rescue and Recovery Workers
Belen Rojano 1 , Erin West 1 , Emily Ferdermann 1 , Steven Markowitz 2, Denise Harrison 3,
Laura Crowley 4, Paula Busse 5, Alex D. Federman 1 and Juan P. Wisnivesky 1,6,*
1 Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai,
New York, NY 10029, USA; belen.rojanobroz@mountsinai.org (B.R.); krystallyn@gmail.com (E.W.);
emily.federmann@mountsinai.org (E.F.); alex.federman@mountsinai.org (A.D.F.)
2 Barry Commoner Center for Health and the Environment, Queens College, City University of New York,
Queens, New York, NY 11367, USA; steven.markowitz@qc.cuny.edu
3 Department of Medicine, New York University School of Medicine, Bellevue Hospital Center,
New York, NY 10016, USA; denise.harrison@nyulangone.org
4 Division of Occupational and Environmental Medicine, Department of Environmental Medicine and Public
Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; laura.crowley@mssm.edu
5 Division of Allergy and Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai,
New York, NY 10029, USA; paula.busse@mssm.edu
6 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Icahn School of
Medicine at Mount Sinai, New York, NY 10029, USA
* Correspondence: juan.wisnivesky@mssm.edu; Tel.: +1-212-8247567
Received: 15 January 2019; Accepted: 22 February 2019; Published: 1 March 2019


Abstract: A large number of World Trade Center (WTC) rescue and recovery workers are affected
by asthma. While physical and mental health comorbidities have been associated with poor asthma
control in this population, the potential role of allergen sensitization is unknown. This study
examined the association of indoor sensitization and exposure as a risk factor for increased asthma
morbidity in WTC workers. We used data from a prospective cohort of 331 WTC workers with
asthma. Sensitization to indoor allergens was assessed by measurement of antigen-specific serum
immunoglobulin E (IgE) levels. We used validated tools to evaluate the exposure to indoor allergens.
Asthma morbidity outcomes included level of control (Asthma Control Questionnaire, ACQ), quality
of life (Asthma Quality of Life Questionnaire, AQLQ) and acute resource utilization. The prevalence
of sensitization to cat, dog, mouse, dust mite, cockroach, and mold allergens were 33%, 21%, 17%, 40%,
17%, and 17%, respectively. Unadjusted and regression analyses showed no significant relationship
between sensitization and increased asthma morbidity (p > 0.05 for all comparisons), except for
sensitization to Aspergillus Fumigatus, cat and mouse epithelium, which were associated with
decreased morbidity.
Keywords: World Trade Center; indoor allergens sensitization; asthma quality of life; asthma control;
asthma outcomes; mini asthma quality of life questionnaire; asthma morbidity; WTC-related asthma;
immunoglobulin E; allergen exposure
1. Introduction
Multiple studies have documented high rates of asthma prevalence (approximately 30%
cumulative incidence, 9 years after exposure) among World Trade Center (WTC) rescue and recovery
workers [1,2]. Recent studies have also demonstrated that many WTC-exposed individuals suffer
from substantial asthma morbidity, including poor disease control and a relatively high number
of emergency room visits and hospitalizations [1]. The reasons for the poor outcomes observed
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among WTC workers are likely multifactorial and partially explained by an increased prevalence of
comorbidities, such as gastroesophageal reflux (GERD) and chronic sinusitis, which are known to
worsen asthma [1,3]. Similarly, post-traumatic stress disorder (PTSD), which has been described in up
to 30% of WTC workers, is strongly associated with increased asthma morbidity [4].
Allergic sensitization is also associated with increased asthma morbidity, particularly in inner-city
children [5,6]. Moreover, environmental remediation strategies to reduce indoor exposures have been
shown to improve asthma control in this population [7,8]. The results of studies assessing the role of
allergic sensitization in adult asthmatics are mixed [9–11]. Nonetheless, anti-immunoglobulin E (IgE)
therapy is effective for antigen-sensitized patients and trigger avoidance is currently recommended as
a major component of asthma self-management by the most recent national asthma guidelines [12].
The role sensitization and exposure to allergens on asthma outcomes in WTC workers has not been
previously explored.
In this study, we determined the rates of sensitization to indoor allergens in a cohort of WTC
workers with asthma, and assessed the relationship to asthma control and acute resource utilization.
2. Materials and Methods
2.1. Study Population
The study was conducted using data from a cohort of WTC workers with a physician diagnosis
of asthma. Study participants were recruited between December 2012 and July 2016, from WTC
workers who were followed by the Mount Sinai Hospital, North Shore-Long Island Jewish Health
System/Queens College, and the New York University School of Medicine WTC Health Program.
Criteria for recruitment into this program have been previously published [4,13] and include
individuals who have volunteered or worked in the lower Manhattan, barge-loading piers or Staten
Island landfill, and workers from the Port Authority Trans Hudson Corporation who were engaged in
cleaning and personnel of the Office of the Chief Medical Examiner who processed human remains.
Lower Manhattan residents, schoolchildren, building occupants, and passers-by were not included in
this registry. Members of the Fire Department of the City of New York (FDNY) who are followed in a
parallel program were also not included in the present study.
The current study was limited to patients with physician-diagnosed asthma who spoke English or
Spanish and were ≥18 years of age at the time of enrollment. We excluded WTC workers with a prior
diagnosis of chronic obstructive lung disease (COPD) and those who had history of >15 pack-years of
smoking, due to the possibility of undiagnosed COPD. We also excluded workers with other chronic
respiratory illnesses. Signed consent was obtained from all participants; the Institutional Review
Boards of the Icahn School of Medicine at Mount Sinai, Queens College and New York University
School of Medicine approved this study.
2.2. Study Variables
Study participants underwent an in-person standardized interview in English or Spanish to
collect sociodemographic information and data regarding asthma history, including onset in relation
to WTC exposure and medication regimen. We obtained information about physician diagnosis of
GERD, allergic rhinitis, and chronic sinusitis, as well as other comorbidities. In order to diagnose
the presence of mental health conditions (PTSD, panic disorder and depression) patients underwent
a structured clinical psychiatric interview (SCID) [14]. According to criteria published in previous
studies, participants were assigned to one of four different groups depending on the level of WTC
exposure: Low, intermediate, high, and very high [1].
2.3. Allergic Sensitization and Exposure Assessments
Sensitization to indoor allergens was assessed using serum IgE levels in peripheral blood; a
level >0.35 kU/L was considered indicative of sensitization [12,15]. The allergens included were,
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cat epithelium and dander, dog, mouse epithelium, house dust mites (Dermatophagoides Farinae and
Dermatophagoides Pteronyssinus), cockroaches (Blatella Germanica or Periplaneta Americana), and molds
(Alternaria Alternata and Aspergillus Fumigatus). Serum IgE levels were determined using the Thermo
Fisher Scientific Analyzer Phadia™ 1000® (Phadia AB, Uppsala, Sweden). Home environmental
exposures were ascertained using survey questions previously validated against findings from home
inspections [16–18]. The survey included questions about the presence of pets at home, visible molds,
mildew, wet spots, and/or cockroaches. In addition, study participants were asked about the presence
of dust at home, home cleaning behaviors, and if the participants kept windows closed during the
allergy seasons.
2.4. Outcomes
We used the Asthma Control Questionnaire (ACQ) to assess the level of asthma control [19].
The ACQ is a validated tool available in English and Spanish and has been extensively used in clinical
practice and research [20]. Higher ACQ scores indicate worse asthma control and a change of >0.5
units is considered clinically significant [19]. The impact of allergic sensitization on quality of life
was assessed with the Mini Asthma Quality of Life Questionnaire (AQLQ) [21]. This validated tool
includes 15 questions in four domains (symptoms, environment, emotions and activities) and has
good reliability and responsiveness [21,22]. A higher score on the AQLQ indicates better quality of life
related to asthma [21]. We also collected information about asthma-related resource utilization (visits
to emergency department, hospitalizations, use of oral corticosteroids) in the previous year.
2.5. Statistical Analysis
The means with standard deviations and percentages with 95% confidence intervals (CI) were
used to describe the baseline characteristics of the study participants. We used the t-test to compare
ACQ and AQLQ scores of WTC workers sensitized versus those not sensitized to each specific indoor
allergen. The chi-square test was used to compare acute resource utilization according to sensitization
status. The adjusted association between sensitization status, ACQ, and AQLQ scores over time
was assessed using linear regression to control for sociodemographic characteristics, asthma history,
asthma onset in relation to 9/11 exposure, asthma regimen, WTC exposure level, and comorbidities.
The potential relationship of acute resource utilization with sensitization to each allergen was evaluated
using logistic regression analysis.
Power calculations showed that a total of approximately 220 patients were required for the study
to have 80% power to detect a clinically significance difference of ≥0.5 units in ACQ and AQLQ
scores among patients sensitized versus not sensitized to each indoor allergen. All statistical tests were
performed with SAS statistical software (SAS Institute, Cary, NC, USA) using 2-tailed tests.
3. Results
3.1. Participant Characteristics
Overall, 373 WTC workers with asthma were enrolled in the study; of these, 42 lacked results for
specific IgE and were excluded from these analyses. The mean (SD) age of study participants was
52.7 (8) years; 73% were male; 35% white, 13% Black, and 43% Hispanic (Table 1). Most WTC workers
(72%) reported asthma onset after WTC exposure and 66% were prescribed an asthma controller
medication. Among the cohort, the frequency of patients with well-controlled, uncontrolled, and
very poorly controlled asthma was 27%, 26%, and 47%, respectively; almost half (49%) reported poor
quality of life. In terms of resource utilization, 20% of WTC workers had a hospitalization or an ER
visit related to their asthma in the previous 12 months, and 27% had received an oral corticosteroid
burst for an exacerbation.
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Table 1. Baseline characteristics of World Trade Center rescue and recovery workers with asthma.
Characteristic Value
Age, years, mean (SD) 52.7 (8)








Did not graduate high school 30 (9)
High School or GED 52 (16)
Some College 135 (41)
College Graduate or More Advanced Degree 114 (34)
Monthly Income < $3,000, No. (%) 183 (55)
Occupation, No. (%)
Employed Full Time 141 (43)
Employed Part Time 35 (10)
Unemployed 19 (6)
On Disability 40 (12)
Retired 72 (22)
Not Working/Student/Other 24 (7)
Smoking Status No. (%)
Current/former Smoker 101 (31)
Never Smoked 220 (66)
Refused/Unknown 10 (3)




Very High 26 (8)
Asthma Onset Post 9/11, No. (%) 242 (72)
Hospitalization/Emergency Room Visit for
Asthma in the Past Year, No. (%) 64 (20)
Oral Corticosteroid Use in Past 12 Months No. (%) 88 (27)
Asthma Control Level, No. (%)
Well Controlled 91 (27)
Uncontrolled 86 (26)
Very Poorly Controlled 154 (47)
Asthma-related Quality of Life, No. (%)
Good 172 (52)
Poor 159 (48)
On Asthma Controller Medication, No. (%) 218 (66)
Comorbidities No. (%)
Gastric Esophageal Reflux Disorder 222 (67)
Sinusitis 207 (63)
Major Depression 88 (27)
Posttraumatic Stress Disorder 81 (24)
SD: standard deviation. No.: Number. WTC: World Trade Center.
Overall, 56% (95% CI: 51–62%) of WTC workers were sensitized to at least one indoor allergen
(Table 2). The frequency of sensitization to cat, dog, mouse epithelium, Dermatophagoides Farinae,
Dermatophagoides Pteronyssines, cockroach, Alternaria Tenuis, and Aspergillus Fumigatus was 33% (95% CI:
28–38%), 21% (95% CI: 17–26%), 17% (95% CI: 13–22%), 34% (95% CI: 30–40%), 32% (95% CI: 26–37%),
17% (95% CI: 13–21%), 11% (95% CI: 7–14%), and 10% (95% CI: 6–15%), respectively. Overall, 50% of
participants had cats, dogs, or birds at home, 17% reported presence of mice/rats at home, 24% had
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observed cockroaches, 20% observed wet spots, 25% had mold/mildew at their home, and only 34%
kept windows closed during the allergy season.
Table 2. Sensitization and exposure to indoor allergens among World Trade Center rescue and recovery
workers with asthma.
Allergen Number Percentage (95% CI)
At least One Indoor Allergens 186 56 (51–62)
Cat Dander 110 33 (28–38)
Dog Dander 63 21 (17–26)
Mouse Epithelium 57 17 (13–22)
Dermatophagoides Farinae 115 34 (29–40)
Dermatophagoides Pteronyssines 105 32 (26–37)
Cockroach 57 17 (13–21)
Alternaria Tenuis 35 11 (7–14)
Aspergillus Fumigatus 20 10 (6–15)
Home Exposures
Cats, dogs or birds living in home 165 50 (44–55)
Mice or rats 58 17 (13–22)
Cockroaches 79 24 (19–29)
Wet spots on walls, wallpaper, ceilings or carpets 68 20 (16–25)
Mold or mildew growing on surfaces 83 25 (20–30)
Keeps windows closed during allergen season 110 34 (29–40)
CI: confidence interval.
3.2. Unadjusted Associations between Sensitization and Asthma Morbidity
Unadjusted analyses showed no significant association between sensitization to most indoor
allergen and ACQ and AQLQ scores (p > 0.05 for all comparisons) (Table 3). Only sensitization to
Aspergillus Fumigatus (mean difference: −0.63; 95% CI: −1.17 to −0.09) was associated with a lower
ACQ score. Similarly, sensitization to at least one allergen (mean difference: 0.29; 95% CI: 0.01 to 0.56),
and sensitization to cat allergens (mean difference: 0.36; 95% CI: 0.08 to 0.65) were associated with
higher AQLQ scores. In addition, the use of oral corticosteroids and acute resource utilization were
not significantly associated with sensitization status to most allergens (p > 0.05 for all comparisons).
However, sensitization to mouse epithelium (OR: 0.39; 95% CI: 0.18–0.86) was associated with a
decreased use of oral corticoids in the year before enrollment. We also found that acute asthma-related
resource utilization was lower in patients sensitized to at least one allergen (OR: 0.54; 95% CI: 0.29–0.99).
Unadjusted analyses also showed no significant interaction between allergen sensitization and WTC
exposure category (p > 0.05 for all comparisons), suggesting the effect of sensitization was not different
according to the level of exposure at the WTC site.
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Table 3. Unadjusted associations between sensitization to indoor allergens and asthma morbidity in
World Trade Center rescue and recovery workers.









Allergen −0.15 (−0.40, 0.09) 0.29 (0.01, 0.56) * 1.24 (0.75, 2.06) 0.54 (0.29, 0.99)
Cat Dander −0.14 (−0.40, 0.11) 0.36 (0.08, 0.65) * 1.51 (0.91, 2.52) 0.66 (0.33, 1.31)
Dog Dander 0.04 (−0.28, 0.35) 0.21 (−0.15, 0.56) 0.83 (0.43, 1.60) 0.58 (0.23, 1.45)
Mouse Epithelium 0.12 (−0.21, 0.44) 0.04 (−0.32, 0.40) 0.39 (0.18, 0.86) * 0.62 (0.25, 1.54)
Dermatophagoides
Farinae 0.03 (−0.23, 0.28) 0.10 (−0.18, 0.39) 1.06 (0.63, 1.77) 0.71 (0.36, 1.38)
Dermatophagoides
Pteronyssines −0.11 (−0.38, 0.15) 0.14 (−0.15, 0.44) 0.76 (0.44, 1.32) 0.75 (0.38, 1.48)
Cockroach −0.04 (−0.37, 0.29) 0.01 (−0.35, 0.37) 0.91 (0.47, 1.77) 0.50 (0.19, 1.33)
Alternaria Tenuis −0.33 (−0.73, 0.06) 0.39 (−0.06, 0.83) 0.55 (0.22, 1.38) 0.32 (0.07, 1.36)
Aspergillus
Fumigatus −0.63 (−1.17, −0.09) * 0.53 (−0.05, 1.12) 0.56 (0.18, 1.77) 0.29 (0.04, 2.25)
CI: confidence interval; OR: odds ratio; OCS: oral corticosteroids, ACQ: Asthma Control Questionnaire, AQLQ:
Asthma Quality of Life Questionnaire. * Statistically significant at a <0.05 level.
3.3. Adjusted Associations between Indoor Sensitization and Asthma Control
Adjusted analyses also showed no statistically significant association between the sensitization to
most allergens and ACQ and AQLQ scores, use of oral steroids, and previous utilization of health care
services (p > 0.05 for all comparisons) (Table 4). However, sensitization to at least one indoor allergen
(mean difference: 0.27; 95% CI: 0.03 to 0.50) or Dermatophagoides Pteronyssines (mean difference:
0.29; 95% CI: 0.03 to 0.55) were significantly associated with higher AQLQ scores. Finally, sensitization
to at least one allergen (OR: 0.41; 95% CI: 0.20–0.85), and cockroach (OR: 0.27; 95% CI: 0.08–0.91) were
significantly associated with lower rates of acute asthma-related resource utilization.
Table 4. Adjusted associations between sensitization to indoor allergens and asthma morbidity in
World Trade Center rescue and recovery workers.
Exposure Mean ACQDifference, 95% CI
Mean AQLQ
Difference, 95% CI





Allergen −0.19 (−0.43, 0.04) 0.27 (0.03, 0.50) * 1.16 (0.65, 2.07) 0.41 (0.20, 0.85) *
Cat Dander −0.09 (−0.34, 0.16) 0.17 (−0.09, 0.43) 1.46 (0.80, 2.66) 0.47 (0.21, 1.06)
Dog Dander −0.06 (−0.37, 0.24) 0.29 (−0.02, 0.61) 0.77 (0.37, 1.62) 0.45 (0.16, 1.27)
Mouse Epithelium 0.20 (−0.11, 0.50) −0.08 (−0.39, 0.24) 0.42 (0.17, 1.02) 0.41 (0.13, 1.31)
Dermatophagoides
Farinae 0.02 (−0.23, 0.27) 0.06 (−0.19, 0.31) 1.10 (0.60, 2.00) 0.48 (0.21, 1.08)
Dermatophagoides
Pteronyssines −0.24 (−0.49, 0.01) 0.29 (0.03, 0.55) * 0.77 (0.40, 1.46) 0.56 (0.24, 1.31)
Cockroach −0.29 (−0.61, 0.03) 0.30 (−0.03, 0.63) 0.81 (0.36, 1.80) 0.27 (0.08, 0.91) *
Alternaria Tenuis −0.10 (−0.48, 0.28) 0.09 (−0.30, 0.48) 0.49 (0.17, 1.38) 0.31 (0.06, 1.60)
Aspergillus
Fumigatus −0.42 (−0.94, 0.10) 0.46 (−0.08, 0.99) 0.42 (0.10, 1.69) 0.44 (0.05, 4.14)
CI: confidence interval; OR: odds ratio; OCS: oral corticosteroids, ACQ: Asthma Control Questionnaire, AQLQ:
Asthma Quality of Life Questionnaire. * Statistically significant at a <0.05 level.
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4. Discussion
Asthma is a common WTC-related condition that is frequently poorly controlled and associated
with substantial healthcare resource utilization [1]. In this study, we found that a large percentage
of WTC workers are sensitized to common indoor allergens, similarly to the general population [23].
However, sensitization to most of the indoor allergens evaluated was not significantly associated with
increased asthma morbidity or acute resource utilization, even among WTC workers exposed to these
allergens. These results suggest that efforts to better control WTC-related asthma should focus on other
established risk factors, such as other medical co-morbidities, PTSD, or low adherence to controller
medication, and other effective self-management behaviors [1,2,4].
There is strong epidemiologic evidence linking allergen sensitization to increased asthma
morbidity in inner-city children [5,6,24,25]. Moreover, the effectiveness of home-based environmental
remediation and multi-trigger interventions in decreasing allergen exposure and reducing asthma
morbidity is well-established [26,27]. Several studies have also evaluated the potential impact of
allergic sensitization on asthma outcomes in adults. Specific allergens, in particular cockroach [5] and
Alternaria [28], have been associated with more severe asthma; asthma deaths have been linked to high
fungal spore counts in the environment [29]. Similarly, a study of 140 inner-city women with asthma
showed a statistically significant association between increased asthma morbidity and exposure to cats
among sensitized patients [30]. A study of elderly inner-city asthmatics showed that patients with high
levels of cockroach-specific IgE had worse disease control and more severe airflow obstruction [10].
Similarly, a study of 5845 adults with asthma showed higher exacerbation rates in those sensitized
to cat or dogs that had these pets at home [31]. Conversely, a study of 245 inner-city adults with
persistent asthma showed no significant relationship between indoor allergen sensitization and asthma
outcomes [9]. The European Respiratory Health Survey showed no association between the levels of
cat allergen and/or sensitization status with asthma symptoms [32]. Our study extends these findings
by showing a lack of association between sensitization and asthma morbidity in WTC workers.
Several factors may explain our findings. WTC-related asthma may be associated with a
higher prevalence of airway neutrophilia [33]. Asthma is characterized by airway inflammation [34],
characterized by an eosinophil-dominated pattern, especially in patients who have allergen-induced
symptoms and an underlying T2 inflammatory profile. However, asthma is a heterogeneous disease
and there is increased evidence that other mechanisms, such as a neutrophil-mediated inflammation,
less often associated with atopy, could lead to enhanced bronchial reactivity and airflow obstruction in
some patients [35]. Th-17 cells appear to play a key role in the pathophysiology of neutrophilic asthma,
a disease often associated with worse control and resistance to inhaled corticosteroids [34,36–43].
Thus, if a larger proportion of WTC workers have neutrophil predominant asthma, it is expected that
sensitization plays a decreased role in the underlying pathophysiology of this asthma phenotype, and
hence its control. Further understanding about the most common patterns of airway inflammation in
WTC workers with asthma is important for personalizing their management.
Many WTC workers have physical and/or mental health comorbidities known to increase
asthma morbidity. These include GERD, chronic sinusitis, and rhinitis, as well as, PTSD, and major
depression [1,3,4]. Thus, these conditions may be more important determinants of the level of asthma
control in WTC workers, rather than the potential impact of allergic sensitization. While prior studies
have showed that there is a strong negative impact of allergic sensitization among inner-city children
with asthma, our cohort was limited to adults, who spent less time at home and therefore are less
exposed to the home indoor environment [44].
Given the relatively high rate of allergen sensitization in our population of WTC workers with
asthma, avoidance of environmental triggers could still contribute to improved control in some of
these patients, particularly those with features of eosinophilic disease. However, our findings suggest
that healthcare providers should also focus on other important asthma triggers in this population,
such as other medical comorbidities and occupational exposures.
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Our study has some limitations that should be mentioned. Our data were collected between
11 and 15 years of the WTC exposure, and therefore our findings represent a narrow window in
time. Despite enrolling a relatively large number of WTC workers, our cohort did not represent all
populations exposed to WTC disaster, such as firefighters, local residents, and passersby. Thus, our
results may not be generalizable to these groups. Our study did not include a non-WTC asthma
control group to assess for potential differences in the role and the impact of allergen sensitization.
WTC rescue and recovery workers are a unique population given their exposures at the WTC site,
range of occupations and associated exposures prior and after 9/11, healthy worker effect, and a high
prevalence of physical and mental health comorbidities, many of which (e.g., GERD and PTSD) are
associated with worse asthma control. Thus, it is very difficult to identify a control group to perform
robust comparisons of the relationship between allergic sensitization and asthma morbidity in WTC
versus no-WTC populations. However, in a prior study of non-WTC asthma patients recruited from
the same institution [9], we found similar rates of sensitization to cats (41%), mouse epithelium (14%),
dust mites (43%), molds (21%) than those reported in our WTC workers cohort. The prevalence of
sensitization to cockroach was higher in the non-WTC asthma cohort (60% vs. 17%) that could be
related to higher levels of cockroach exposure in this inner-city population and may explain some of
the differences in our results. In this non-WTC population, adjusted analyses showed that allergy to
cockroach, dust mites, cat, mouse, or molds were not associated with increased resource utilization or
worse asthma outcomes. Some exceptions were the presence of dust mite sensitization that was related
to increased use of oral steroids in the year before enrollment, mouse sensitization that was related
with an increased number of hospitalizations, and cat sensitization that showed decreased number to
ED visits during the follow up period. Similarly, our adjusted analyses showed significant associations
between sensitization to some allergens (Dermatophagoides Pteronyssines and cockroach) with markers
of decreased asthma morbidity. We used objective measures of allergen sensitization and validated
cut-offs, however, we did not collect home samples to assess the actual levels of environmental
exposure. Although self-reported measures may be subject to bias, we used validated items that have
been correlated to direct home environmental assessments [16,21,22]. Similarly, we used validated
instruments to assess asthma control and quality of life in study participants. We did not evaluate IgE
sensitization to outdoor allergens, as they play a limited role in asthma exacerbations [45]. We found
that sensitization to some allergens was associated with improved asthma control. However, these
relationships were inconsistent across different asthma outcomes for specific allergens, and thus, more
likely related to random sampling. Conversely, our study was not powered to find small differences in
asthma control and quality of life among sensitized WTC workers; however, our sample was sufficient
for identifying clinically meaningful differences in these outcomes. Finally, we did not assess the
potential impact of outdoor allergens on asthma morbidity levels of WTC workers.
5. Conclusions
In summary, we found no significant associations between indoor allergen sensitization and
exposure to asthma morbidity in WTC workers. Given the high rates of the absence of asthma control
and decreased quality of life in this population, our findings can guide providers in their management
strategies for WTC workers with asthma.
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